Summary of Glenmark Pharmaceuticals Limited 48th Annual General Meeting

Meeting Details

The 48th AGM was held on Friday, September 11, 2026, at 2:00 PM IST through Video Conferencing (VC)/Other Audio Visual Means (OAVM), with a webcast facility provided to members. The meeting was presided over by Mr. Glenn Saldanha, Chairman cum Managing Director & CEO. All directors of the board were present, including the chairpersons of the Audit Committee, Nomination and Remuneration Committee, Stakeholders Relationship Committee, Risk Management Committee, and CSR Committee. The Chief Financial Officer and Company Secretary were also present. Representatives of Statutory Auditors, Cost Auditors, Secretarial Auditors, and Scrutinizers attended via VC. A total of 54 shareholders attended the meeting.

Business Transacted

The following five resolutions were presented for shareholder approval:

Ordinary Business:

1. Adoption of Audited Standalone Financial Statements for FY ended March 31, 2026, with reports of Board of Directors and Auditors.

2. Adoption of Audited Consolidated Financial Statements for FY ended March 31, 2026, with report of Auditors.

3. Declaration of dividend of ₹2.50 per equity share for FY ended March 31, 2026.

Special Business:

4. Re-appointment of Mrs. Blanche Saldanha as a Non-Executive Director, liable to retire by rotation.

5. Ratification of remuneration of the Cost Auditor for FY ending March 31, 2027.

Voting Process and Results

The company provided e-voting facilities through National Securities Depository Limited (NSDL). Remote e-voting commenced on September 8, 2026, at 9:00 AM IST and ended on September 10, 2026, at 5:00 PM IST. E-voting was also available during the AGM for members who had not voted remotely. M/s. Mehta & Mehta, Company Secretaries, were appointed as Scrutinizer to conduct the e-voting process.

The consolidated voting results for each resolution are as follows:

Item 1 (Ordinary Resolution - Adoption of Standalone Financial Statements):

  • Voted in favour: 839 members, 230,105,389 shares (99.9227%)
  • Voted against: 13 members, 177,952 shares (0.0773%)
  • Resolution passed by requisite majority.

Item 2 (Ordinary Resolution - Adoption of Consolidated Financial Statements):

  • Voted in favour: 788 members, 220,789,273 shares (95.8772%)
  • Voted against: 64 members, 9,494,068 shares (4.1228%)
  • Resolution passed by requisite majority.

Item 3 (Ordinary Resolution - Dividend Declaration of ₹2.50 per share):

  • Voted in favour: 844 members, 230,704,654 shares (99.9998%)
  • Voted against: 12 members, 490 shares (0.0002%)
  • Resolution passed by requisite majority.

Item 4 (Special Resolution - Re-appointment of Mrs. Blanche Saldanha):

  • Voted in favour: 824 members, 230,154,580 shares (99.7725%)
  • Voted against: 32 members, 524,783 shares (0.2275%)
  • Resolution passed since votes in favor were more than three times votes against.

Item 5 (Ordinary Resolution - Ratification of Cost Auditor Remuneration):

  • Voted in favour: 839 members, 230,677,949 shares (99.9998%)
  • Voted against: 15 members, 574 shares (0.0002%)
  • Resolution passed by requisite majority.

Additional Meeting Proceedings

The Company Secretary informed members that the Notice of AGM along with the Integrated Annual Report for FY 2025-26 was sent electronically. The Statutory Auditors' Report and Secretarial Audit Report contained no qualifications, reservations, or adverse remarks. The Chairman delivered a speech covering the company's performance in FY 2025-26, innovation, commercial foundation, quality growth, and future vision. The company received requests from 15 members to speak during the AGM, with 14 actually participating. Mr. Glenn Saldanha and Mr. Anurag Mantri responded to queries raised by members.

The meeting concluded at 2:00 PM, after which the e-voting facility remained open for 30 minutes. The meeting was officially declared closed at 3:51 PM.